We are live on ! Find out more
N

NanoDimension Portfolio holdings

AUM $24.7M
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-4.91%
1 Year Est. Return
-74.01%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.7M
AUM Growth
-$5.89M
Cap. Flow
-$2.73M
Cap. Flow %
-11.09%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ICVX
Icosavax, Inc. Common Stock
ICVX
+$2.34M
2
RNAC icon
Cartesian Therapeutics
RNAC
+$394K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWST icon
1
Twist Bioscience
TWST
$5.62B
$10.8M 43.99%
307,740
– –
RNAC icon
2
Cartesian Therapeutics
RNAC
$232M
$6.21M 25.2%
126,251
-7,166
-5% -$394K
ICVX
3
DELISTED
Icosavax, Inc. Common Stock
ICVX
$4.3M 17.45%
1,361,658
-374,256
-22% -$2.34M
SQZ
4
DELISTED
SQZ Biotechnologies Company
SQZ
$3.29M 13.36%
1,445,221
– –

Similar funds

AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return
GX
Greylock XIII Menlo Park, California $27.6M AUM 53.47% 1-Year Est. Return
FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
KL
Kokino LLC Stamford, Connecticut $28M AUM 16.9% 1-Year Est. Return
A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return

NanoDimension's Q3 2022 Portfolio in Review

As of Q3 2022, NanoDimension held 4 positions worth $24.7M, down 19% from $30.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

NanoDimension withdrew a net $2.73M in Q3 2022, reducing 2 holdings. Its largest reduction was Icosavax, Inc. Common Stock, cutting an estimated $2.34M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • NanoDimension's biggest Q3 2022 reduction was Icosavax, Inc. Common Stock, cutting an estimated $2.34M.
  • NanoDimension's ten largest holdings make up 100% of its $24.7M portfolio in Q3 2022.
  • NanoDimension opened 0 new positions and closed 0 in Q3 2022.
  • NanoDimension's portfolio value fell 19% quarter-over-quarter to $24.7M.

Based on NanoDimension's 13F filing for Q3 2022, filed 9 Nov 2022.